KFDA approves two amlodipine versions

The Korea Food and Drug Administration said on June 23 it approved two amlodipine maleate versions of Chong Kun Dang and Choong-wae, following the recent approvals of another amolodipine salts by SK Pharm and Hanmi.

In the domestic antihypertensive market where Pfizer's Norvasc (amlodipine mesylate) with sales revenue of 150 billion won last year, a total of 13 Korean pharmaceutical manufact...